Arosol Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 8.00 M
as on 03-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.94 Cr
as on 03-07-2024
- Satisfied Charges ₹ 1.78 Cr
as on 03-07-2024
- Revenue -2.15%
(FY 2023)
- Profit 10.08%
(FY 2023)
- Ebitda -13.29%
(FY 2023)
- Net Worth 10.15%
(FY 2023)
- Total Assets 11.10%
(FY 2023)
About Arosol Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹5.94 Cr. The company has closed loans amounting to ₹1.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nidhi Arora, Anshul Arora, Shalini Arora, and One other member serve as directors at the Company.
- CIN/LLPIN
U24211UP2007PTC033144
- Company No.
033144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Saharanpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Arosol Pharmaceuticals Private Limited offer?
Arosol Pharmaceuticals Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Poultry Feed, Animal Feed Supplement, Fertilizer, Bio Fertilizers, Pet Furniture & Products, Pet Grooming Tools, Micronutrient Fertilizers, Chelated Calcium, Feed Additives.
Who are the key members and board of directors at Arosol Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nidhi Arora  | Director | 20-Feb-2018 | Current |
| Anshul Arora | Director | 11-Apr-2007 | Current |
| Shalini Arora | Director | 11-Apr-2007 | Current |
| Krishan Arora | Director | 11-Apr-2007 | Current |
Financial Performance of Arosol Pharmaceuticals.
Arosol Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.15% decrease. The company also saw a substantial improvement in profitability, with a 10.08% increase in profit. The company's net worth Soared by an impressive increase of 10.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arosol Pharmaceuticals?
In 2023, Arosol Pharmaceuticals had a promoter holding of 55.13% and a public holding of 44.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nutricare Life Sciences LimitedActive 10 years 6 monthsNidhi Arora, Anshul Arora and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Nov 2022 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 21 Mar 2013 | ₹5.79 Cr | Open |
Punjab National Bank Creation Date: 06 Sep 2010 | ₹1.65 M | Satisfied |
How Many Employees Work at Arosol Pharmaceuticals?
Arosol Pharmaceuticals has a workforce of 81 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arosol Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arosol Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
